Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1Classical hematology 1

Conditions

Thrombocytopenia 2Lymphoma 2Leukemia 2Hematologic Diseases 2Transfusion Reaction 1Leukemia, Myeloid, Acute 1

Interventions

pirtobrutinib 5Lenalidomide 4Rituximab 3Imatinib Mesylate 3ruxolitinib 2ponatinib 2ibrutinib 2Platelet Transfusion 2Brentuximab Vedotin 2Bortezomib 2Bendamustine Hydrochloride 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2zanubrutinib 1vosaroxin 1venetoclax 1nilotinib 1idelalisib 1bosutinib 1acalabrutinib 1Zoledronic Acid 1Vorinostat 1Vincristine 1Tretinoin 1Prednisone 1Plasma Exchange 1Granulocyte-Macrophage Colony-Stimulating Factor 1Exercise 1Doxorubicin 1Dexamethasone 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Hematologic Diseases × Platelet Transfusion × Clear all
NCT00000589 2016-11-07

Trial to Reduce Alloimmunization to Platelets (TRAP)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
Other hematologic neoplasm

Hematologic Diseases, Leukemia, Myeloid, Acute

NCT00074763 2012-08-02

Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets

M.D. Anderson Cancer Center

Phase 3 Terminated
4 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡